Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Andres Henao Martinez

Concepts (492)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Chagas Disease
13
2023
33
7.260
Why?
Chagas Cardiomyopathy
7
2023
21
4.390
Why?
Meningitis, Cryptococcal
8
2024
29
3.680
Why?
Cryptococcosis
6
2023
25
3.440
Why?
Opportunistic Infections
4
2024
46
2.630
Why?
Trypanosoma cruzi
6
2023
24
2.430
Why?
Cryptococcus neoformans
4
2024
19
1.870
Why?
Invasive Pulmonary Aspergillosis
2
2023
5
1.720
Why?
HIV Infections
10
2024
2703
1.640
Why?
Travel
6
2021
121
1.620
Why?
Strongyloidiasis
2
2024
4
1.430
Why?
Cryptococcus
2
2024
7
1.430
Why?
Immunocompromised Host
6
2024
195
1.340
Why?
Stroke, Lacunar
2
2019
4
1.270
Why?
Anti-Bacterial Agents
9
2025
1689
1.190
Why?
Tuberculosis
2
2022
271
1.170
Why?
Transients and Migrants
3
2023
25
1.170
Why?
Candidemia
2
2024
8
1.160
Why?
Humans
104
2025
128020
1.160
Why?
Hospitalization
7
2024
2057
1.120
Why?
Cardiomyopathies
2
2021
335
1.100
Why?
Yellow Fever
3
2022
7
1.080
Why?
Bacteremia
5
2023
192
1.030
Why?
Infectious Disease Transmission, Vertical
2
2019
170
1.010
Why?
Candida
2
2024
35
0.990
Why?
Glucocorticoids
3
2024
572
0.970
Why?
Antifungal Agents
8
2023
128
0.970
Why?
Central Nervous System Neoplasms
2
2018
148
0.960
Why?
Adult
37
2025
35177
0.920
Why?
Macrolides
1
2025
62
0.920
Why?
Parasitemia
2
2015
11
0.910
Why?
Pneumocystis
1
2024
11
0.900
Why?
Risk Factors
15
2024
9696
0.890
Why?
Mycoses
1
2024
70
0.890
Why?
Pneumonia, Pneumocystis
1
2024
34
0.890
Why?
Drug Hypersensitivity
1
2025
81
0.870
Why?
Pulmonary Aspergillosis
1
2023
3
0.870
Why?
Nitroimidazoles
1
2023
9
0.870
Why?
Pneumonia, Viral
7
2020
337
0.850
Why?
Coronavirus Infections
7
2020
333
0.840
Why?
Myocarditis
2
2016
98
0.840
Why?
Anemia, Aplastic
1
2023
35
0.840
Why?
AIDS-Related Opportunistic Infections
1
2024
123
0.830
Why?
Male
45
2025
62758
0.820
Why?
Enterobacteriaceae Infections
2
2013
37
0.810
Why?
Zoonoses
2
2024
27
0.800
Why?
Virus Diseases
1
2024
209
0.780
Why?
Antigens, Fungal
2
2024
27
0.750
Why?
Immunotherapy, Adoptive
1
2024
295
0.740
Why?
Neglected Diseases
1
2020
4
0.720
Why?
Mycobacterium Infections
2
2018
61
0.710
Why?
Hepatitis
1
2020
47
0.700
Why?
Middle Aged
24
2025
30813
0.680
Why?
Hantavirus Pulmonary Syndrome
1
2020
3
0.680
Why?
Heart Aneurysm
1
2019
10
0.670
Why?
Epidemics
1
2020
82
0.650
Why?
Massive Hepatic Necrosis
1
2019
3
0.650
Why?
Aneurysm, False
1
2019
48
0.640
Why?
United States
19
2024
13785
0.640
Why?
Hepatitis A
1
2019
25
0.640
Why?
Leukemia, Myelomonocytic, Chronic
1
2018
2
0.620
Why?
Neisseria gonorrhoeae
1
2019
24
0.620
Why?
Sarcoma, Myeloid
1
2018
4
0.620
Why?
Hematoma, Subdural
1
2018
17
0.620
Why?
Female
36
2025
68017
0.590
Why?
Plasmodium falciparum
1
2018
29
0.590
Why?
Malaria, Falciparum
1
2018
26
0.590
Why?
Skin
3
2022
711
0.590
Why?
Gonorrhea
1
2019
57
0.590
Why?
Fever
2
2020
295
0.590
Why?
Chromoblastomycosis
1
2017
1
0.580
Why?
Hand Dermatoses
1
2017
7
0.580
Why?
Renal Insufficiency
1
2020
148
0.580
Why?
Population Groups
1
2018
58
0.580
Why?
Dyspnea
1
2019
238
0.570
Why?
Delayed Diagnosis
1
2018
79
0.570
Why?
Meningioma
1
2018
80
0.570
Why?
Meningeal Neoplasms
1
2018
93
0.570
Why?
Medically Uninsured
1
2018
127
0.560
Why?
Abscess
1
2018
73
0.560
Why?
Milk
1
2018
119
0.550
Why?
Heart Failure
2
2022
2141
0.550
Why?
Pandemics
10
2023
1473
0.540
Why?
Retrospective Studies
12
2024
14404
0.540
Why?
Osteomyelitis
1
2019
123
0.540
Why?
Latin America
6
2022
86
0.530
Why?
Poliomyelitis
3
2022
36
0.530
Why?
Trichuriasis
1
2016
4
0.520
Why?
Prisons
4
2021
79
0.520
Why?
Pregnancy Complications, Parasitic
1
2016
9
0.520
Why?
Lymphocytosis
1
2016
10
0.520
Why?
Neoplasms, Unknown Primary
1
2016
13
0.520
Why?
Pregnancy Complications, Hematologic
1
2016
18
0.520
Why?
Enterobacteriaceae
2
2013
35
0.520
Why?
Parotid Neoplasms
1
2016
16
0.520
Why?
Occupational Diseases
1
2017
138
0.510
Why?
Diphyllobothriasis
1
2015
2
0.500
Why?
Diphyllobothrium
1
2015
2
0.500
Why?
Colombia
4
2020
36
0.500
Why?
Plasmablastic Lymphoma
1
2015
7
0.500
Why?
Insect Vectors
1
2015
27
0.490
Why?
Pre-Exposure Prophylaxis
1
2018
202
0.490
Why?
Gamma Rays
1
2015
53
0.490
Why?
Plasma Cells
1
2015
65
0.480
Why?
Transplants
1
2015
35
0.480
Why?
Lymphoma
1
2016
194
0.470
Why?
Anemia
1
2016
160
0.460
Why?
Bone Marrow
1
2016
267
0.460
Why?
Heart Ventricles
1
2019
765
0.460
Why?
Proto-Oncogene Proteins c-akt
2
2023
419
0.450
Why?
Thrombocytopenia
1
2016
184
0.440
Why?
Environmental Exposure
1
2018
458
0.430
Why?
Transplant Recipients
1
2015
152
0.430
Why?
Aged
12
2024
21892
0.430
Why?
Research
1
2016
408
0.420
Why?
Betacoronavirus
6
2020
247
0.420
Why?
Myocardial Contraction
1
2015
333
0.420
Why?
Lymphoma, Primary Effusion
1
2013
3
0.420
Why?
Thrombocytosis
1
2013
6
0.420
Why?
Lymphoma, AIDS-Related
1
2013
14
0.410
Why?
Methicillin-Resistant Staphylococcus aureus
4
2023
215
0.400
Why?
Herpesvirus 8, Human
1
2013
59
0.400
Why?
Antigens, Protozoan
1
2012
22
0.400
Why?
Acinetobacter Infections
1
2012
10
0.400
Why?
Acinetobacter
1
2012
13
0.400
Why?
Proctitis
1
2012
6
0.390
Why?
Herpes Genitalis
1
2012
16
0.390
Why?
H-2 Antigens
1
2012
115
0.390
Why?
Herpesvirus 2, Human
1
2012
28
0.390
Why?
Cellulitis
1
2012
48
0.390
Why?
Incidence
3
2025
2614
0.380
Why?
Isoxazoles
1
2012
54
0.380
Why?
Yellow Fever Vaccine
2
2022
5
0.380
Why?
Severe Dengue
1
2011
10
0.380
Why?
Herpesviridae Infections
1
2013
134
0.380
Why?
Acyclovir
1
2012
99
0.370
Why?
Healthcare Disparities
3
2024
579
0.370
Why?
Emigration and Immigration
2
2022
50
0.370
Why?
Animals
15
2024
34487
0.360
Why?
Treatment Outcome
11
2024
10110
0.360
Why?
B-Lymphocytes
1
2016
812
0.350
Why?
Poliovirus
2
2022
82
0.350
Why?
Pancreatitis
1
2011
128
0.350
Why?
Magnetic Resonance Imaging
2
2019
3371
0.340
Why?
Acute Lung Injury
1
2013
264
0.330
Why?
Moraxella
1
2009
5
0.330
Why?
Moraxellaceae Infections
1
2009
3
0.330
Why?
Lung Diseases
2
2018
713
0.330
Why?
Repressor Proteins
1
2013
399
0.330
Why?
Lupus Nephritis
1
2009
49
0.320
Why?
Databases, Factual
2
2025
1264
0.320
Why?
Diabetes Mellitus, Type 2
1
2023
2428
0.320
Why?
Fluconazole
3
2023
17
0.320
Why?
Young Adult
9
2024
12282
0.310
Why?
Pulmonary Emphysema
1
2011
244
0.310
Why?
Biomarkers, Tumor
1
2015
1175
0.310
Why?
Aged, 80 and over
5
2024
7029
0.310
Why?
Arthritis, Infectious
1
2009
57
0.310
Why?
Presenilin-1
1
2008
31
0.300
Why?
Fatal Outcome
2
2019
299
0.290
Why?
Immunoglobulin G
3
2023
842
0.290
Why?
Engineering
1
2018
25
0.290
Why?
Social Responsibility
1
2018
47
0.290
Why?
Staphylococcal Infections
3
2023
386
0.280
Why?
Echinocandins
2
2023
7
0.270
Why?
Mycobacterium
2
2018
106
0.270
Why?
Positron Emission Tomography Computed Tomography
2
2018
84
0.270
Why?
Antineoplastic Combined Chemotherapy Protocols
1
2015
1558
0.270
Why?
Public Health
3
2020
478
0.270
Why?
Antiviral Agents
1
2012
710
0.260
Why?
Attitude
1
2018
250
0.250
Why?
HIV
2
2018
225
0.250
Why?
Sepsis
2
2022
562
0.250
Why?
Clinical Trials as Topic
2
2020
997
0.250
Why?
Electrocardiography
2
2019
607
0.250
Why?
Propensity Score
2
2023
264
0.240
Why?
Shock, Septic
2
2021
207
0.240
Why?
Acute Kidney Injury
1
2013
777
0.240
Why?
Clarithromycin
1
2025
28
0.240
Why?
Erythromycin
1
2025
24
0.240
Why?
Candida tropicalis
1
2024
4
0.240
Why?
Polymorphism, Genetic
1
2008
638
0.240
Why?
Cross Reactions
1
2025
129
0.230
Why?
Insect Bites and Stings
1
2024
11
0.230
Why?
Strongyloides stercoralis
1
2024
2
0.230
Why?
Azithromycin
1
2025
91
0.230
Why?
Colorado
3
2020
4369
0.220
Why?
Teicoplanin
2
2023
15
0.220
Why?
Peru
2
2024
53
0.220
Why?
World Health Organization
2
2021
110
0.220
Why?
Toxoplasmosis
1
2023
36
0.220
Why?
Anaphylaxis
1
2025
98
0.210
Why?
Toxoplasma
1
2023
38
0.210
Why?
Meningoencephalitis
1
2023
25
0.210
Why?
Alanine
1
2024
141
0.210
Why?
Voriconazole
1
2023
20
0.210
Why?
Rabies
1
2022
1
0.210
Why?
Rabies Vaccines
1
2022
2
0.210
Why?
Predictive Value of Tests
2
2019
1934
0.210
Why?
Antiparasitic Agents
1
2022
3
0.200
Why?
Glycopeptides
1
2023
44
0.200
Why?
Pyridones
1
2024
158
0.200
Why?
Students
1
2018
570
0.200
Why?
Tenofovir
1
2024
231
0.200
Why?
Kaplan-Meier Estimate
1
2024
851
0.200
Why?
Tomography, X-Ray Computed
4
2019
2509
0.200
Why?
Dog Diseases
1
2022
52
0.200
Why?
Americas
1
2022
21
0.200
Why?
Drug Therapy, Combination
2
2018
1012
0.200
Why?
Pregnancy
4
2024
6355
0.200
Why?
Prognosis
3
2022
3766
0.200
Why?
Sexually Transmitted Diseases
1
2024
150
0.200
Why?
Alzheimer Disease
1
2008
515
0.200
Why?
Disease Notification
1
2022
12
0.190
Why?
Italy
1
2022
97
0.190
Why?
Travel Medicine
2
2020
5
0.190
Why?
Staphylococcal Skin Infections
2
2012
34
0.190
Why?
Leprosy
1
2021
21
0.190
Why?
Rural Population
2
2022
511
0.190
Why?
Proportional Hazards Models
1
2024
1194
0.190
Why?
Acquired Immunodeficiency Syndrome
1
2023
223
0.190
Why?
Population Dynamics
1
2022
136
0.180
Why?
Leishmania guyanensis
1
2020
1
0.180
Why?
Case-Control Studies
3
2018
3324
0.180
Why?
Antiprotozoal Agents
1
2020
13
0.180
Why?
Leishmaniasis, Cutaneous
1
2020
9
0.180
Why?
Phosphorylcholine
1
2020
18
0.180
Why?
Personal Protective Equipment
1
2021
50
0.170
Why?
Pericarditis
1
2020
11
0.170
Why?
Anti-Inflammatory Agents
1
2024
467
0.170
Why?
Weight Gain
1
2024
503
0.170
Why?
Receptors, Interleukin-6
1
2020
37
0.170
Why?
Tumor Necrosis Factor-alpha
2
2022
1185
0.170
Why?
Communicable Diseases, Emerging
1
2020
30
0.170
Why?
Africa
1
2020
98
0.170
Why?
Late Onset Disorders
1
2019
1
0.170
Why?
Immunization, Secondary
1
2020
87
0.170
Why?
Developing Countries
1
2022
285
0.170
Why?
Immunosuppressive Agents
1
2024
682
0.170
Why?
Bolivia
1
2019
63
0.160
Why?
Proteinuria
1
2020
88
0.160
Why?
Gram-Positive Bacterial Infections
1
2020
65
0.160
Why?
Infection Control
1
2021
136
0.160
Why?
Genetic Predisposition to Disease
1
2008
2261
0.160
Why?
Prospective Studies
4
2023
7035
0.160
Why?
Invasive Fungal Infections
1
2019
10
0.160
Why?
Sexual and Gender Minorities
1
2022
193
0.160
Why?
Amphotericin B
1
2019
29
0.160
Why?
Medical Errors
1
2020
104
0.160
Why?
Cryptococcus gattii
1
2018
1
0.160
Why?
Acute Disease
2
2012
961
0.160
Why?
Observational Studies as Topic
1
2019
108
0.160
Why?
Vulnerable Populations
1
2020
157
0.160
Why?
Dermatitis
1
2018
19
0.160
Why?
Speech Disorders
1
2018
34
0.150
Why?
Echocardiography
2
2020
623
0.150
Why?
Computed Tomography Angiography
1
2019
115
0.150
Why?
Africa, Western
1
2018
17
0.150
Why?
Stroke Volume
1
2021
588
0.150
Why?
Administration, Intravenous
1
2019
137
0.150
Why?
Emigrants and Immigrants
1
2020
122
0.150
Why?
Antibodies, Neutralizing
1
2020
263
0.150
Why?
Sex Factors
1
2024
1942
0.150
Why?
Raw Foods
1
2018
2
0.150
Why?
California
1
2019
398
0.150
Why?
Time Factors
2
2019
6479
0.150
Why?
Neoplasms
1
2013
2460
0.150
Why?
Ventricular Function, Left
1
2021
524
0.150
Why?
Administration, Oral
2
2020
766
0.150
Why?
Itraconazole
1
2017
6
0.150
Why?
Food Microbiology
1
2018
58
0.140
Why?
Respiration, Artificial
1
2022
600
0.140
Why?
Prisoners
1
2020
141
0.140
Why?
Arrhythmias, Cardiac
1
2020
314
0.140
Why?
Georgia
1
2017
78
0.140
Why?
Hyponatremia
1
2018
40
0.140
Why?
Longitudinal Studies
2
2019
2706
0.140
Why?
Cytokines
2
2022
1984
0.140
Why?
Disability Evaluation
1
2019
285
0.140
Why?
Patient Safety
1
2020
286
0.140
Why?
Research Design
2
2021
1034
0.140
Why?
Farmers
1
2017
67
0.130
Why?
Mebendazole
1
2016
2
0.130
Why?
Strongyloides
1
2016
2
0.130
Why?
Trichuris
1
2016
3
0.130
Why?
Antibodies, Viral
1
2020
601
0.130
Why?
Albendazole
1
2016
5
0.130
Why?
Arachis
1
2017
108
0.130
Why?
Ivermectin
1
2016
13
0.130
Why?
Patient Acceptance of Health Care
1
2022
756
0.130
Why?
Pharmacists
1
2019
246
0.130
Why?
Drug-Related Side Effects and Adverse Reactions
1
2019
251
0.130
Why?
Interleukin-6
1
2020
712
0.130
Why?
Socioeconomic Factors
2
2020
1211
0.130
Why?
Hematocrit
1
2016
93
0.130
Why?
Evidence-Based Medicine
1
2020
709
0.130
Why?
Hospitals, University
1
2016
176
0.130
Why?
Vaccination
2
2022
1343
0.130
Why?
Brain
1
2008
2615
0.130
Why?
Praziquantel
1
2015
5
0.130
Why?
Anthelmintics
1
2015
10
0.130
Why?
Clone Cells
1
2016
255
0.120
Why?
Diagnosis, Differential
1
2020
1408
0.120
Why?
Disease Outbreaks
3
2023
339
0.120
Why?
Mental Disorders
1
2023
1005
0.120
Why?
Genotype
2
2012
1828
0.120
Why?
Recurrence
1
2018
993
0.120
Why?
Lipids
1
2019
619
0.120
Why?
Health Care Costs
1
2018
366
0.120
Why?
Academic Medical Centers
1
2018
478
0.120
Why?
Migraine Disorders
1
2016
83
0.120
Why?
Herpesvirus 4, Human
1
2015
152
0.120
Why?
Proto-Oncogene Proteins c-myc
1
2015
130
0.110
Why?
Hearing Loss
1
2018
210
0.110
Why?
Frontal Lobe
1
2015
153
0.110
Why?
Adrenal Cortex Hormones
1
2018
518
0.110
Why?
Biopsy
2
2020
1077
0.110
Why?
Multivariate Analysis
1
2018
1492
0.110
Why?
Heart Transplantation
1
2020
711
0.110
Why?
Hemoglobins
1
2016
336
0.110
Why?
Delivery of Health Care
1
2021
888
0.110
Why?
Health Status Disparities
3
2020
254
0.110
Why?
Parasite Load
1
2013
8
0.100
Why?
Mycoplasma hominis
1
2012
4
0.100
Why?
Mycoplasma Infections
1
2012
14
0.100
Why?
APACHE
1
2013
65
0.100
Why?
Klebsiella Infections
1
2013
23
0.100
Why?
Intestines
1
2016
344
0.100
Why?
Platelet Count
1
2013
82
0.100
Why?
Disease Progression
2
2012
2598
0.100
Why?
Logistic Models
1
2018
1975
0.100
Why?
Molecular Typing
1
2012
19
0.100
Why?
Clindamycin
1
2012
13
0.100
Why?
Comorbidity
2
2022
1537
0.100
Why?
Feces
1
2015
435
0.100
Why?
Child
6
2023
20636
0.100
Why?
Serratia Infections
1
2012
6
0.100
Why?
Syncope
1
2013
50
0.100
Why?
Anti-HIV Agents
2
2024
749
0.100
Why?
Serratia marcescens
1
2012
13
0.100
Why?
Linkage Disequilibrium
1
2013
256
0.100
Why?
Central America
2
2023
21
0.100
Why?
Lymphoma, Non-Hodgkin
1
2013
76
0.100
Why?
Disease Eradication
2
2022
4
0.100
Why?
Mice, Inbred BALB C
1
2015
1227
0.100
Why?
Thoracic Vertebrae
1
2012
74
0.090
Why?
Hedgehog Proteins
1
2013
187
0.090
Why?
Viral Load
2
2024
449
0.090
Why?
Trimethoprim, Sulfamethoxazole Drug Combination
1
2011
37
0.090
Why?
Blister
1
2011
40
0.090
Why?
Tumor Suppressor Protein p53
1
2015
504
0.090
Why?
Microscopy
1
2013
140
0.090
Why?
Drug Resistance, Bacterial
1
2012
170
0.090
Why?
Drug Resistance, Viral
1
2012
110
0.090
Why?
Poliovirus Vaccine, Oral
2
2022
25
0.090
Why?
Soft Tissue Infections
1
2011
35
0.090
Why?
Venezuela
2
2021
7
0.090
Why?
Spinal Fractures
1
2012
81
0.090
Why?
Prevalence
1
2018
2541
0.090
Why?
Myocardium
1
2016
967
0.090
Why?
HIV Seropositivity
1
2011
119
0.090
Why?
Coinfection
1
2012
131
0.090
Why?
Cross Infection
1
2013
199
0.090
Why?
Urinary Tract Infections
1
2012
144
0.090
Why?
Gene Expression
1
2015
1454
0.090
Why?
Cross-Sectional Studies
2
2019
5034
0.090
Why?
Community-Acquired Infections
1
2012
153
0.090
Why?
Cohort Studies
3
2022
5378
0.090
Why?
Lupus Erythematosus, Systemic
1
2013
244
0.080
Why?
Penicillanic Acid
1
2009
4
0.080
Why?
Mice
3
2023
16574
0.080
Why?
Piperacillin
1
2009
8
0.080
Why?
Bacterial Typing Techniques
1
2009
42
0.080
Why?
Surgical Wound Infection
1
2012
281
0.080
Why?
Debridement
1
2009
82
0.080
Why?
Spinal Cord Injuries
1
2012
191
0.080
Why?
Anti-Infective Agents
1
2011
243
0.080
Why?
Hypertension
1
2018
1234
0.080
Why?
Infusions, Intravenous
1
2009
390
0.080
Why?
Needs Assessment
2
2021
356
0.070
Why?
Mortality
2
2021
306
0.070
Why?
Genes, Dominant
1
2008
90
0.070
Why?
Socialization
1
2018
24
0.070
Why?
Chromosome Disorders
1
2008
39
0.070
Why?
Global Health
2
2020
327
0.070
Why?
Point Mutation
1
2008
221
0.070
Why?
Amino Acid Substitution
1
2008
280
0.070
Why?
Genetic Markers
1
2008
338
0.070
Why?
DNA Mutational Analysis
1
2008
384
0.070
Why?
Pedigree
1
2008
485
0.070
Why?
Gene Frequency
1
2008
504
0.070
Why?
Intensive Care Units
2
2023
734
0.070
Why?
Chronic Disease
1
2012
1690
0.060
Why?
Wounds and Injuries
1
2012
705
0.060
Why?
Kidney Failure, Chronic
1
2011
540
0.060
Why?
Amyloid beta-Peptides
1
2008
211
0.060
Why?
Gene Expression Regulation
1
2015
2508
0.060
Why?
Polymorphism, Single Nucleotide
1
2013
2059
0.060
Why?
Adenocarcinoma
1
2012
888
0.060
Why?
Genetic Testing
1
2008
428
0.060
Why?
Registries
1
2013
1873
0.060
Why?
Interviews as Topic
1
2018
714
0.060
Why?
Antivenins
1
2024
35
0.060
Why?
Prostatic Neoplasms
1
2012
1011
0.060
Why?
Mice, Inbred C57BL
1
2015
5268
0.060
Why?
Moths
1
2024
38
0.060
Why?
Aminobutyrates
1
2024
33
0.060
Why?
Drug Substitution
1
2024
51
0.060
Why?
Peptide Fragments
1
2008
688
0.060
Why?
Acetazolamide
1
2023
24
0.050
Why?
Antibodies, Protozoan
1
2023
32
0.050
Why?
Human Rights
1
2023
18
0.050
Why?
Seroepidemiologic Studies
1
2023
155
0.050
Why?
Adolescent
4
2023
20158
0.050
Why?
HIV Integrase Inhibitors
1
2024
69
0.050
Why?
Panama
1
2022
11
0.050
Why?
Yellow fever virus
1
2022
3
0.050
Why?
Medicine, Traditional
1
2022
22
0.050
Why?
Monkeypox virus
1
2022
13
0.050
Why?
Triazoles
1
2024
150
0.050
Why?
Standard of Care
1
2023
72
0.050
Why?
CD4 Lymphocyte Count
1
2023
267
0.050
Why?
Poliovirus Vaccine, Inactivated
1
2022
28
0.050
Why?
Cell Line
1
2008
2736
0.050
Why?
Immunoglobulin M
1
2023
272
0.050
Why?
Vancomycin
1
2023
78
0.050
Why?
Disease Models, Animal
1
2012
3936
0.050
Why?
Mexico
1
2022
190
0.050
Why?
Adenine
1
2024
255
0.050
Why?
Cameroon
1
2021
8
0.050
Why?
Cuba
1
2021
11
0.050
Why?
Mycobacterium leprae
1
2021
8
0.050
Why?
Contact Tracing
1
2021
23
0.050
Why?
Microbial Sensitivity Tests
1
2023
348
0.050
Why?
Healthy Volunteers
1
2022
199
0.050
Why?
Surveys and Questionnaires
2
2019
5353
0.050
Why?
Dogs
1
2022
368
0.050
Why?
Antineoplastic Agents
1
2013
2041
0.050
Why?
Curriculum
1
2018
909
0.050
Why?
Homosexuality, Male
1
2022
175
0.050
Why?
Minority Health
1
2021
20
0.040
Why?
Cardiovascular Infections
1
2020
2
0.040
Why?
Pericardiocentesis
1
2020
10
0.040
Why?
Meta-Analysis as Topic
1
2021
169
0.040
Why?
History, 17th Century
1
2020
14
0.040
Why?
Minority Groups
1
2022
250
0.040
Why?
Inflammation
2
2022
2646
0.040
Why?
Bone Diseases, Infectious
1
2020
8
0.040
Why?
Pregnancy Complications, Infectious
1
2024
363
0.040
Why?
Hemorrhage
1
2024
643
0.040
Why?
Social Justice
1
2021
77
0.040
Why?
Network Meta-Analysis
1
2020
9
0.040
Why?
Crowding
1
2020
35
0.040
Why?
Outpatients
1
2023
366
0.040
Why?
Communicable Disease Control
1
2020
70
0.040
Why?
Policy Making
1
2020
87
0.040
Why?
Catheter-Related Infections
1
2020
67
0.040
Why?
Brazil
1
2020
154
0.040
Why?
Signal Transduction
1
2013
4812
0.040
Why?
History, 21st Century
1
2020
177
0.040
Why?
Frail Elderly
1
2020
121
0.040
Why?
History, 20th Century
1
2020
285
0.040
Why?
Cough
1
2020
115
0.040
Why?
Staphylococcus aureus
1
2023
434
0.040
Why?
Southeastern United States
1
2018
34
0.040
Why?
Skilled Nursing Facilities
1
2020
129
0.040
Why?
Quality Assurance, Health Care
1
2021
315
0.040
Why?
Drug Compounding
1
2019
96
0.040
Why?
Social Determinants of Health
1
2022
220
0.040
Why?
Nursing Homes
1
2020
154
0.040
Why?
Immunization Schedule
1
2020
196
0.040
Why?
HIV-1
1
2024
833
0.040
Why?
Immunologic Factors
1
2020
227
0.040
Why?
Residence Characteristics
1
2020
324
0.040
Why?
Risk
1
2020
850
0.040
Why?
Polymerase Chain Reaction
1
2020
1020
0.040
Why?
Critical Illness
1
2023
755
0.030
Why?
Organ Transplantation
1
2020
218
0.030
Why?
Urban Population
1
2020
440
0.030
Why?
Hospitals
1
2022
631
0.030
Why?
Models, Theoretical
1
2020
541
0.030
Why?
Occupational Exposure
1
2020
299
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2020
754
0.030
Why?
Mass Screening
1
2022
1145
0.030
Why?
Diabetes Mellitus, Type 1
1
2011
3625
0.030
Why?
Electrophoresis, Gel, Pulsed-Field
1
2012
19
0.030
Why?
Molecular Epidemiology
1
2012
63
0.020
Why?
Risk Assessment
1
2020
3223
0.020
Why?
Infant
1
2021
8912
0.020
Why?
Lung
1
2020
3745
0.020
Why?
Dose-Response Relationship, Drug
1
2011
1943
0.020
Why?
Child, Preschool
1
2021
10378
0.020
Why?
Henao Martinez's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description
Physical Neighbors Expand Description
_

Copyright © 2025 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)